Literature DB >> 6126871

Controlled trial of terfenadine and chlorpheniramine maleate in perennial rhinitis.

J Brostoff, J D Lockhart.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126871      PMCID: PMC2426514          DOI: 10.1136/pgmj.58.681.422

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  3 in total

1.  Performance studies with antihistamines.

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  Some clinical pharmacological studies with terfenadine, a new antihistamine drug.

Authors:  V K Kulshrestha; P P Gupta; P Turner; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

3.  Clinical investigation of terfenadine, a non-sedating antihistamine.

Authors:  M L Brandon; M Weiner
Journal:  Ann Allergy       Date:  1980-02
  3 in total
  7 in total

Review 1.  Respiratory and allergic disease. I.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

Review 2.  Terfenadine. The first nonsedating antihistamine.

Authors:  H C Masheter
Journal:  Clin Rev Allergy       Date:  1993

Review 3.  Optimum pharmacological management of chronic rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Drugs       Date:  1989-08       Impact factor: 9.546

Review 4.  Pharmacologic treatment of rhinitis.

Authors:  F E Simons; K J Simons
Journal:  Clin Rev Allergy       Date:  1984-08

Review 5.  Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  E M Sorkin; R C Heel
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

6.  Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.

Authors:  Patrick W Sullivan; Sheryl L Follin; Michael B Nichol
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 7.  Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:  D McTavish; K L Goa; M Ferrill
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.